ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. (TSX-PLI.SV) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary enabling technology, the Mimetic Ligand™. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in Therapeutic Drug Development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of inflammation and cancer. Its drug discovery platform is focussed on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montréal (Canada), ProMetic has R&D and manufacturing facilities in the UK and business development activities in the US, Europe, Asia and MENA countries (Middle East and North Africa).